Nadav Kidron - Jan 3, 2022 Form 4/A - Amendment Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Signature
/s/ Nadav Kidron
Stock symbol
ORMP
Transactions as of
Jan 3, 2022
Transactions value $
-$677,165
Form type
4/A - Amendment
Date filed
1/11/2022, 07:30 PM
Date Of Original Report
Jan 5, 2022
Previous filing
Dec 30, 2021
Next filing
Aug 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +150K +19.57% 916K Jan 3, 2022 Direct F1
transaction ORMP Common Stock Tax liability -$677K -48.8K -5.32% $13.89 868K Jan 3, 2022 Direct F2
transaction ORMP Common Stock Award +63K +7.26% 931K Jan 3, 2022 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORMP Stock Option (right to buy Award $0 +107K $0.00 107K Jan 3, 2022 Common Stock 107K $13.89 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock granted by the Issuer that vested upon grant.
F2 Payment of tax liability by withholding securities incident to the 150,000 shares of Common Stock granted on January 3, 2022.
F3 Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 15,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F4 This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Kidron, which reported that 950,729 shares of common stock are beneficially owned by him following the reported transactions. Mr. Kidron beneficially owned 930,729 shares of common stock following the reported transactions.
F5 The Stock Option will vest in 4 installments as follows: 26,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.